Changchun GeneScience Pharmaceutical Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1948-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://english.ciac.cas.cn/
Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China
- First Posted Date
- 2017-10-18
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT03313219
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, China
Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
- First Posted Date
- 2017-09-21
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1500
- Registration Number
- NCT03290235
- Locations
- 🇨🇳
TongJi hospital affiliated to TongJi medical college of HuaZhong university of Science & Teconology, Wuhan, Hubei, China
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 360
- Registration Number
- NCT03255694
- Locations
- 🇨🇳
Department of Pediatrics of Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Wuhan, Hubei, China
🇨🇳The First Affiated Hospital of Nanjing Medical Universit, Nanjing, Jiangsu, China
🇨🇳The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 900
- Registration Number
- NCT03249480
- Locations
- 🇨🇳
China-Japan Friendship Hospital, Beijing, China
🇨🇳Children's Hospital of Hebei Province, Shijiazhuang, Hebei, China
🇨🇳Children's Hospital of Soochow University, Suzhou, Jiangsu, China
A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)
- Conditions
- Interventions
- First Posted Date
- 2017-08-10
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT03245333
- Locations
- 🇨🇳
Beijing Children's Hospital, Capital Medical University, Beijing, China
🇨🇳Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
🇨🇳Shanghai Children's Hospital, Shanghai, China
A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA
- Conditions
- Interventions
- First Posted Date
- 2017-07-19
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT03221933
- Locations
- 🇨🇳
Shanghai Children's Hospital, Shanghai, China
🇨🇳The first affiliated Hospital with Nanjing Medical Universit, Nanjing, Jiangsu, China
🇨🇳Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature
- Conditions
- Interventions
- First Posted Date
- 2017-07-18
- Last Posted Date
- 2017-07-19
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 360
- Registration Number
- NCT03221088
- Locations
- 🇨🇳
The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
🇨🇳Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China
🇨🇳Shanghai Children's Hospital of Fudan University, Shanghai, China
A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome
- Conditions
- Interventions
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT03189160
- Locations
- 🇨🇳
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
🇨🇳Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China
🇨🇳Beijing Children's Hospital,Capital Medical University, Beijing, China
A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD
- First Posted Date
- 2017-04-07
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT03104010
- Locations
- 🇨🇳
Heibei General Hospital, Shijiazhuang, Hebei, China
🇨🇳Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳West China Hospital, Sichuan University, Chengdu, Sichuan, China
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
- First Posted Date
- 2017-03-06
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 252
- Registration Number
- NCT03071172
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
🇨🇳Peking University Third Hospital, Beijing, China
🇨🇳The first Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China